Paving the way for commercial exports of Covid-19 vaccines to start from India, the Centre allowed Hyderabad-based vaccine maker Bharat Biotech to start commercial exports of Covaxin on Tuesday, according to sources in the know.
A few days back, its peer Pune’s Serum Institute of India (SII), was allowed to export to the WHO-led vaccine initiative COVAX.
Bharat Biotech did not wish to comment on the matter. SII, too, did not confirm if it got a nod to start commercial bilateral exports from the Indian government.
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.
Subscribe To Insights
Key stories on business-standard.com are available to premium subscribers only.Already a BS Premium subscriber? Log in NOW
Or